Kyle Diamantas, the acting commissioner of the FDA, is expected to be a drama-free, stabilizing caretaker at the top of the agency.
Kyle Diamantas is acting commissioner of the FDA.FDA
By Adam Feuerstein
May 14, 2026
Senior Writer, Biotech
Adam Feuerstein
Acting FDA leader tries to explain past Planned Parenthood work to abortion opponents
Pharma leaders hope next FDA head calms waters
FDA’s leadership void leaves biotech with renewed ‘uncertainty’
Bill Cassidy says new FDA chief lacks drug and medical device experience
Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?
Biopharma industry endorses Pazdur for FDA commissioner role - Pharmaceutical Technology
Makary’s time atop FDA over, Diamantas named acting commissioner
FDA shuffles top drug, biologics leaders in latest shakeup
FDA drug center head fired after commissioner's exit, replaced by Davis
Trump's FDA head faces calls to meet the moment on abortion pill regulation
WASHINGTON — People in the food world didn’t know what to expect when the Trump administration appointed a little-known Florida…
Acting FDA commissioner Kyle Diamantas doesn't want the permanent job, and the search for a replacement is progressing, a source…
Kyle Diamantas, who was elevated to FDA acting commissioner earlier this week, is telling anti-abortion groups he asked to be…
With the FDA facing upheaval and personnel exits, former commissioner David Kessler sees an opportunity whereby the agency can…
The agency may not have permanent leadership until after the midterms, says one expert
They called for stability and predictability at the agency at Axios' Future of Health summit.
